vs
Astrana Health, Inc.（ASTH）与博思艾伦汉密尔顿（BAH）财务数据对比。点击上方公司名可切换其他公司
博思艾伦汉密尔顿的季度营收约是Astrana Health, Inc.的2.8倍（$2.6B vs $950.5M）。博思艾伦汉密尔顿净利率更高（7.6% vs 0.7%，领先6.9%）。Astrana Health, Inc.同比增速更快（42.9% vs -10.2%）。博思艾伦汉密尔顿自由现金流更多（$248.0M vs $-6.0M）。过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs -2.8%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
博思艾伦汉密尔顿控股集团是美国知名专业服务企业，深耕数字化转型与人工智能领域，为公共部门、私营机构及非营利组织提供咨询、分析与工程服务，总部位于弗吉尼亚州麦克莱恩，属华盛顿大都会区，在全球另设有80个办事处。
ASTH vs BAH — 直观对比
营收规模更大
BAH
是对方的2.8倍
$950.5M
营收增速更快
ASTH
高出53.1%
-10.2%
净利率更高
BAH
高出6.9%
0.7%
自由现金流更多
BAH
多$253.9M
$-6.0M
两年增速更快
ASTH
近两年复合增速
-2.8%
损益表 — Q4 2025 vs Q3 2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $2.6B |
| 净利润 | $6.6M | $200.0M |
| 毛利率 | — | 51.9% |
| 营业利润率 | 1.9% | 8.8% |
| 净利率 | 0.7% | 7.6% |
| 营收同比 | 42.9% | -10.2% |
| 净利润同比 | 184.4% | 7.0% |
| 每股收益（稀释后） | $0.12 | $1.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHBAH
| Q4 25 | $950.5M | $2.6B | ||
| Q3 25 | $956.0M | $2.9B | ||
| Q2 25 | $654.8M | $2.9B | ||
| Q1 25 | $620.4M | $3.0B | ||
| Q4 24 | $665.2M | $2.9B | ||
| Q3 24 | $478.7M | $3.1B | ||
| Q2 24 | $486.3M | $2.9B | ||
| Q1 24 | $404.4M | $2.8B |
净利润ASTHBAH
| Q4 25 | $6.6M | $200.0M | ||
| Q3 25 | $373.0K | $175.0M | ||
| Q2 25 | $9.4M | $271.0M | ||
| Q1 25 | $6.7M | $192.7M | ||
| Q4 24 | $-7.8M | $186.9M | ||
| Q3 24 | $16.1M | $390.1M | ||
| Q2 24 | $19.2M | $165.2M | ||
| Q1 24 | $14.8M | $128.0M |
毛利率ASTHBAH
| Q4 25 | — | 51.9% | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 51.3% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 55.2% | ||
| Q3 24 | — | 56.7% | ||
| Q2 24 | — | 53.4% | ||
| Q1 24 | — | 54.7% |
营业利润率ASTHBAH
| Q4 25 | 1.9% | 8.8% | ||
| Q3 25 | 2.0% | 9.8% | ||
| Q2 25 | 3.1% | 8.8% | ||
| Q1 25 | 3.3% | 9.2% | ||
| Q4 24 | 0.1% | 10.0% | ||
| Q3 24 | 5.9% | 17.4% | ||
| Q2 24 | 6.2% | 8.7% | ||
| Q1 24 | 7.5% | 9.5% |
净利率ASTHBAH
| Q4 25 | 0.7% | 7.6% | ||
| Q3 25 | 0.0% | 6.1% | ||
| Q2 25 | 1.4% | 9.3% | ||
| Q1 25 | 1.1% | 6.5% | ||
| Q4 24 | -1.2% | 6.4% | ||
| Q3 24 | 3.4% | 12.4% | ||
| Q2 24 | 3.9% | 5.6% | ||
| Q1 24 | 3.7% | 4.6% |
每股收益（稀释后）ASTHBAH
| Q4 25 | $0.12 | $1.63 | ||
| Q3 25 | $0.01 | $1.42 | ||
| Q2 25 | $0.19 | $2.16 | ||
| Q1 25 | $0.14 | $1.52 | ||
| Q4 24 | $-0.14 | $1.45 | ||
| Q3 24 | $0.33 | $3.01 | ||
| Q2 24 | $0.40 | $1.27 | ||
| Q1 24 | $0.31 | $0.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $882.0M |
| 总债务越低越好 | — | $3.9B |
| 股东权益账面价值 | $779.3M | $1.0B |
| 总资产 | $2.2B | $7.1B |
| 负债/权益比越低杠杆越低 | — | 3.84× |
8季度趋势，按日历期对齐
现金及短期投资ASTHBAH
| Q4 25 | $429.5M | $882.0M | ||
| Q3 25 | $463.4M | $816.0M | ||
| Q2 25 | $342.1M | $711.0M | ||
| Q1 25 | $260.9M | $885.0M | ||
| Q4 24 | $290.8M | $453.5M | ||
| Q3 24 | $350.3M | $558.7M | ||
| Q2 24 | $327.7M | $297.7M | ||
| Q1 24 | $337.3M | $554.3M |
总债务ASTHBAH
| Q4 25 | — | $3.9B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | — | $4.0B | ||
| Q1 25 | — | $4.0B | ||
| Q4 24 | — | $3.4B | ||
| Q3 24 | — | $3.4B | ||
| Q2 24 | — | $3.4B | ||
| Q1 24 | — | $3.4B |
股东权益ASTHBAH
| Q4 25 | $779.3M | $1.0B | ||
| Q3 25 | $775.5M | $996.0M | ||
| Q2 25 | $765.5M | $1.1B | ||
| Q1 25 | $745.4M | $1.0B | ||
| Q4 24 | $712.7M | $1.2B | ||
| Q3 24 | $704.6M | $1.2B | ||
| Q2 24 | $678.9M | $1.1B | ||
| Q1 24 | $653.5M | $1.0B |
总资产ASTHBAH
| Q4 25 | $2.2B | $7.1B | ||
| Q3 25 | $2.2B | $7.2B | ||
| Q2 25 | $1.4B | $7.2B | ||
| Q1 25 | $1.3B | $7.3B | ||
| Q4 24 | $1.4B | $6.8B | ||
| Q3 24 | $1.3B | $6.9B | ||
| Q2 24 | $1.3B | $6.6B | ||
| Q1 24 | $1.2B | $6.6B |
负债/权益比ASTHBAH
| Q4 25 | — | 3.84× | ||
| Q3 25 | — | 3.98× | ||
| Q2 25 | — | 3.74× | ||
| Q1 25 | — | 3.99× | ||
| Q4 24 | — | 2.79× | ||
| Q3 24 | — | 2.83× | ||
| Q2 24 | — | 3.14× | ||
| Q1 24 | — | 3.26× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $261.0M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $248.0M |
| 自由现金流率自由现金流/营收 | -0.6% | 9.5% |
| 资本支出强度资本支出/营收 | 0.3% | 0.5% |
| 现金转化率经营现金流/净利润 | -0.44× | 1.30× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $933.4M |
8季度趋势，按日历期对齐
经营现金流ASTHBAH
| Q4 25 | $-2.9M | $261.0M | ||
| Q3 25 | $10.0M | $421.0M | ||
| Q2 25 | $90.9M | $119.0M | ||
| Q1 25 | $16.6M | $219.0M | ||
| Q4 24 | $-10.9M | $150.8M | ||
| Q3 24 | $34.0M | $587.1M | ||
| Q2 24 | $23.2M | $52.1M | ||
| Q1 24 | $6.0M | $143.8M |
自由现金流ASTHBAH
| Q4 25 | $-6.0M | $248.0M | ||
| Q3 25 | $7.4M | $395.0M | ||
| Q2 25 | $89.5M | $96.0M | ||
| Q1 25 | $13.6M | $194.4M | ||
| Q4 24 | $-13.5M | $133.6M | ||
| Q3 24 | $31.7M | $563.3M | ||
| Q2 24 | $20.4M | $19.7M | ||
| Q1 24 | $5.6M | $127.6M |
自由现金流率ASTHBAH
| Q4 25 | -0.6% | 9.5% | ||
| Q3 25 | 0.8% | 13.7% | ||
| Q2 25 | 13.7% | 3.3% | ||
| Q1 25 | 2.2% | 6.5% | ||
| Q4 24 | -2.0% | 4.6% | ||
| Q3 24 | 6.6% | 17.9% | ||
| Q2 24 | 4.2% | 0.7% | ||
| Q1 24 | 1.4% | 4.6% |
资本支出强度ASTHBAH
| Q4 25 | 0.3% | 0.5% | ||
| Q3 25 | 0.3% | 0.9% | ||
| Q2 25 | 0.2% | 0.8% | ||
| Q1 25 | 0.5% | 0.8% | ||
| Q4 24 | 0.4% | 0.6% | ||
| Q3 24 | 0.5% | 0.8% | ||
| Q2 24 | 0.6% | 1.1% | ||
| Q1 24 | 0.1% | 0.6% |
现金转化率ASTHBAH
| Q4 25 | -0.44× | 1.30× | ||
| Q3 25 | 26.69× | 2.41× | ||
| Q2 25 | 9.65× | 0.44× | ||
| Q1 25 | 2.48× | 1.14× | ||
| Q4 24 | — | 0.81× | ||
| Q3 24 | 2.11× | 1.50× | ||
| Q2 24 | 1.21× | 0.32× | ||
| Q1 24 | 0.40× | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
BAH
| Defense Clients | $1.5B | 55% |
| Civil Clients | $732.0M | 28% |
| Intelligence Clients | $434.0M | 17% |
